CAS: 2080306-23-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY 299 REF: IN-DA01E3PFCAS: 2080306-23-4 | 98% | 119.00 €~549.00 € | Tue 03 Dec 24 |
 | BAY 299 REF: 3D-BB163665CAS: 2080306-23-4 | (Hplc-Ms) Min. 98 Area-% | To inquire | Tue 14 Jan 25 |
 | BAY-299 REF: TM-T14502CAS: 2080306-23-4 | 97.5% | 50.00 €~414.00 € | Tue 21 Jan 25 |
Ref: IN-DA01E3PF
| 1mg | 119.00 € | ||
| 5mg | 167.00 € | ||
| 10mg | 275.00 € | ||
| 25mg | 549.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
BAY 299
CAS:2080306-23-4
Inhibitor of BRPF2 and TAF1 bromodomains
Formula:
C25H23N3O4
Purity:
(Hplc-Ms) Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
429.47 g/mol
Ref: 3D-BB163665
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
BAY-299
CAS:2080306-23-4
BAY-299 inhibits BRPF2, TAF1, and TAF1L with IC50s of 67, 8, and 106 nM.
Formula:
C25H23N3O4
Purity:
97.5%
Color and Shape:
Solid
Molecular weight:
429.47
Ref: TM-T14502
| 5mg | 50.00 € | ||
| 10mg | 75.00 € | ||
| 25mg | 138.00 € | ||
| 50mg | 235.00 € | ||
| 100mg | 414.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
